Clinical Trial Update: Clinical Trial of MG-K10 in Stage III of Moderate to Severe Asthma [Phase 3]

View source ↗

Summary

Phase 3 clinical trial of MG-K10 for moderate to severe asthma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• MG-K10

Snippet

Sponsor: Shanghai Mabgeek Biotech.Co.Ltd | Conditions: Asthma | Phase 3 | Status: RECRUITING